Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L.

Slides:

Advertisements

Similar presentations

Sixth INTERMACS annual report: A 10,000-patient database James K. Kirklin, MD, David C. Naftel, PhD, Francis D. Pagani, MD, PhD, Robert L. Kormos, MD,

Advertisements

James K. Kirklin, MD, Francis D. Pagani, MD, PhD, Robert L

Manuel J. Antunes, MD, PhD, DSc

Aortic valve replacement in low-flow, low-gradient aortic stenosis: Left ventricular ejection fraction matters Victor Dayan, MD, PhD, Philippe Pibarot,

Fifth INTERMACS annual report: Risk factor analysis from more than 6,000 mechanical circulatory support patients James K. Kirklin, MD, David C. Naftel,

A wolf in sheep's clothing

Long-term mechanical circulatory support: A new disease state?

New logos The Journal of Thoracic and Cardiovascular Surgery

Stenting of an outflow graft obstruction after implantation of a continuous-flow, axial-flow left ventricular assist device Duc Thinh Pham, MD, Navin.

Does the method of lung preservation influence outcome after transplantation? An analysis of 681 consecutive procedures J. Saravana Ganesh, FRCS, Chris.

Building a bioartificial heart: A 3-song saga

Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices Ranjit John, MD, Kenneth Liao,

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic.

Form ever follows function

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Outcomes of contemporary mechanical circulatory support device configurations in patients with severe biventricular failure Allison P. Levin, BA, MSc,

Long-term mechanical circulatory support (destination therapy): On track to compete with heart transplantation? James K. Kirklin, MD, David C. Naftel,

Resuscitation practices in cardiac surgery

Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

The lord of the rings Antonio Miceli, MD, PhD

Ventricular assist device abdominal driveline infection: Treatment with platelet-rich plasma Federica Jiritano, MD, Giuseppe Filiberto Serraino, MD,

Outcomes after implantation of partial-support left ventricular assist devices in inotropic- dependent patients: Do we still need full-support assist devices?

Successful cardiac transplant after Berlin Heart bridge in a single ventricle heart: Use of aortopulmonary shunt as a supplementary source of pulmonary.

A technique for implanting outflow cannulas for Berlin Heart EXCOR ventricular assist device in small pediatric patients Khanh Nguyen, MD The Journal.

Expanding left ventricular assist device use to patients with disabilities: The role of assistive technology Juan A. Crestanello, MD The Journal of.

Discussions in Cardiothoracic Treatment and Care: Mechanical Circulatory Support Left Ventricular Assist Device Therapy for Patients With Advanced Heart.

Intra-aortic balloon pumps and continuous flow left ventricular assist devices: Don't let balloon pumps overstay their welcome Kevin G. Soucy, PhD, Steven.

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Left ventricular assist device therapy in a patient with hearing and speech disabilities Sotirios Spiliopoulos, MD, PhD, Vera Hergesell, MD, Otto Dapunt,

Michael Mack, MD, David Taggart, MD

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

A first start for lung transplantation?

Right ventricular failure after cardiac surgery: Why can't right ventricular assist device support fix the problem? Francis D. Pagani, MD, PhD The Journal.

William L. Holman, MD, James K. Kirklin, MD, David C

Third-time lung transplantation in a patient with cystic fibrosis

Chronic obstructive pulmonary disease severity influences outcomes after off-pump coronary artery bypass Benjamin Medalion, MD, Michael G. Katz, MD,

Jason M. Gauthier, MD, Ruben G. Nava, MD, Daniel Kreisel, MD, PhD

Commentary: Faster recovery after complex neonatal cardiac surgery

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Niv Ad, MD, Lawrence M. Wei, MD

Frozen elephant trunk technique: Ready to get back to the future?

Attachment disorder in thoracoabdominal surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Jay K. Bhama, MD, Utsav Bansal, BS, Daniel G. Winger, MS, Jeffrey J

Left ventricular assist device implantation after acute anterior wall myocardial infarction and cardiogenic shock: A two-center study Nicholas C. Dang,

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Commentary: “Isn't cardiac surgery a team sport?”

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

The continuing challenge of congenital heart disease in China

Cerebrovascular accidents in patients with a ventricular assist device

Optimal timing of cardiac transplantation after ventricular assist device implantation James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD,

Seeing is believing: A call for routine early postoperative hemodynamic transesophageal echocardiography monitoring after left ventricular assist device.

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Optimal timing for heart transplantation in patients bridged with left ventricular assist devices: Is timing of the essence? Chase R. Brown, MD, Fabliha.

Why arch curvature affects arch resistance

Daisuke Yoshioka, MD, Hiroo Takayama, MD, Arthur R. Garan, MD, Veli K

Gastrointestinal bleeding after left ventricular assist device implantation: It is all about the platelets Juan A. Crestanello, MD The Journal of Thoracic.

How do we follow up our patients

Hari R. Mallidi, MD The Journal of Thoracic and Cardiovascular Surgery

Lessons learned from Melody valve retrieved at transplantation

Presentation transcript:

Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011 William L. Holman, MD, David C. Naftel, PhD, Chad E. Eckert, PhD, Robert L. Kormos, MD, Daniel J. Goldstein, MD, James K. Kirklin, MD The Journal of Thoracic and Cardiovascular Surgery Volume 146, Issue 2, Pages 437-441.e1 (August 2013) DOI: 10.1016/j.jtcvs.2013.02.018 Copyright © 2013 Terms and Conditions

Figure 1 The intervals to device exchange or device-related death for all causes are depicted for pulsatile and continuous flow ventricular assist devices (P < .0001; pulsatile vs continuous flow ventricular assist devices). The Journal of Thoracic and Cardiovascular Surgery 2013 146, 437-441.e1DOI: (10.1016/j.jtcvs.2013.02.018) Copyright © 2013 Terms and Conditions

Figure 2 Deaths and device exchanges from drive unit failure are shown for pulsatile and continuous flow ventricular assist devices (P < .0001; pulsatile vs continuous flow ventricular assist devices). The Journal of Thoracic and Cardiovascular Surgery 2013 146, 437-441.e1DOI: (10.1016/j.jtcvs.2013.02.018) Copyright © 2013 Terms and Conditions

Figure 3 Interval to device exchange or patient death from intractable device-related infection is depicted for pulsatile and continuous flow ventricular assist devices (P < .0363; pulsatile vs continuous flow ventricular assist devices). The Journal of Thoracic and Cardiovascular Surgery 2013 146, 437-441.e1DOI: (10.1016/j.jtcvs.2013.02.018) Copyright © 2013 Terms and Conditions

Figure 4 A, Competing outcomes (cardiac transplantation, death, survival on mechanical circulatory support device, and recovery of the native heart) for patients with continuous flow ventricular assist devices. B, Competing outcomes (cardiac transplantation, death, survival on mechanical circulatory support device, and recovery of the native heart) for patients with pulsatile ventricular assist devices. The Journal of Thoracic and Cardiovascular Surgery 2013 146, 437-441.e1DOI: (10.1016/j.jtcvs.2013.02.018) Copyright © 2013 Terms and Conditions

Figure E1 Deaths and device exchanges from driveline failure are shown for pulsatile and continuous flow ventricular assist devices (P < .8218; pulsatile vs continuous flow ventricular assist devices). The Journal of Thoracic and Cardiovascular Surgery 2013 146, 437-441.e1DOI: (10.1016/j.jtcvs.2013.02.018) Copyright © 2013 Terms and Conditions

Figure E2 Deaths and device exchanges from thrombosis/hemolysis are shown for pulsatile and continuous flow ventricular assist devices (P < .2501; pulsatile vs continuous flow ventricular assist devices). The Journal of Thoracic and Cardiovascular Surgery 2013 146, 437-441.e1DOI: (10.1016/j.jtcvs.2013.02.018) Copyright © 2013 Terms and Conditions